Article Detail - JF Part A
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58997) - R2 - Effective January 01, 2023
This coverage article has been revised and published for notice under contract numbers: 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).
Effective Date: January 01, 2023
Summary of Article Changes: Under CPT/HCPCS Codes Group 1: Codes the description was revised for 81450. Under CPT/HCPCS Codes Group 4: Codes the description was revised for 81450. This is due to the 2023 Annual/Q1 CPT/HCPCS Code Update and is effective for dates of services on or after 1/1/2023.
Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.